Home - Products - Others - Other Targets - PalMitoyl Tripeptide-1 Acetate

PalMitoyl Tripeptide-1 Acetate

CAS No. 1628252-62-9

PalMitoyl Tripeptide-1 Acetate( —— )

Catalog No. M37919 CAS No. 1628252-62-9

PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG 168 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    PalMitoyl Tripeptide-1 Acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.
  • Description
    PalMitoyl Tripeptide-1 Acetate is a form of the extracellular matrix-derived peptide containing palmitic acid.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1628252-62-9
  • Formula Weight
    638.84
  • Molecular Formula
    C32H58N6O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    NCCCC[C@@H](C(O)=O)NC([C@H](CC1=CNC=N1)NC(CNC(CCCCCCCCCCCCCCC)=O)=O)=O.CC(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • DDAO

    DDAO is a promising near-infrared (NIR) red fluorescent probe?with long?emission wavelength?(λem?=?656?nm) and tunable excitation wavelength (600-650?nm).

  • N-Nornuciferine

    N-Nornuciferine, an aporphine alkaloid in lotus leaf, significantly inhibits CYP2D6 (IC50: 3.76 μM, Ki: 2.34 μM).

  • Siplizumab

    Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody that targets CD2, selectively depleting effector memory T cells and promoting the relative expansion of alloreactive regulatory T cells in vitro. Siplizumab can be used to treat plaque psoriasis.